Roubelakis MG - Search Results

1

Proteomics Analysis of Formalin Fixed Paraffin Embedded Tissues in the Investigation of Prostate Cancer.

Mantsiou A, Makridakis M, Fasoulakis K, Katafigiotis I, Constantinides CA, Zoidakis J, Roubelakis MG, Vlahou A, Lygirou V. Mantsiou A, et al. Among authors: roubelakis mg. J Proteome Res. 2020 Jul 2;19(7):2631-2642. doi: 10.1021/acs.jproteome.9b00587. Epub 2019 Nov 18. J Proteome Res. 2020. PMID: 31682457 Free article.

2

Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells.

Roubelakis MG, Pappa KI, Bitsika V, Zagoura D, Vlahou A, Papadaki HA, Antsaklis A, Anagnou NP. Roubelakis MG, et al. Stem Cells Dev. 2007 Dec;16(6):931-52. doi: 10.1089/scd.2007.0036. Stem Cells Dev. 2007. PMID: 18047393

3

Chromosomal and proteome analysis of a new T24-based cell line model for aggressive bladder cancer.

Makridakis M, Gagos S, Petrolekas A, Roubelakis MG, Bitsika V, Stravodimos K, Pavlakis K, Anagnou NP, Coleman J, Vlahou A. Makridakis M, et al. Among authors: roubelakis mg. Proteomics. 2009 Jan;9(2):287-98. doi: 10.1002/pmic.200800121. Proteomics. 2009. PMID: 19105184

4

Analysis of secreted proteins for the study of bladder cancer cell aggressiveness.

Makridakis M, Roubelakis MG, Bitsika V, Dimuccio V, Samiotaki M, Kossida S, Panayotou G, Coleman J, Candiano G, Anagnou NP, Vlahou A. Makridakis M, et al. Among authors: roubelakis mg. J Proteome Res. 2010 Jun 4;9(6):3243-59. doi: 10.1021/pr100189d. J Proteome Res. 2010. PMID: 20423150

5

In vitro and in vivo properties of distinct populations of amniotic fluid mesenchymal progenitor cells.

Roubelakis MG, Bitsika V, Zagoura D, Trohatou O, Pappa KI, Makridakis M, Antsaklis A, Vlahou A, Anagnou NP. Roubelakis MG, et al. J Cell Mol Med. 2011 Sep;15(9):1896-913. doi: 10.1111/j.1582-4934.2010.01180.x. J Cell Mol Med. 2011. PMID: 21166769 Free PMC article.

6

Human amniotic fluid-derived mesenchymal stem cells as therapeutic vehicles: a novel approach for the treatment of bladder cancer.

Bitsika V, Roubelakis MG, Zagoura D, Trohatou O, Makridakis M, Pappa KI, Marini FC, Vlahou A, Anagnou NP. Bitsika V, et al. Among authors: roubelakis mg. Stem Cells Dev. 2012 May 1;21(7):1097-111. doi: 10.1089/scd.2011.0151. Epub 2011 Oct 11. Stem Cells Dev. 2012. PMID: 21988169

7

Profilin 1 is a potential biomarker for bladder cancer aggressiveness.

Zoidakis J, Makridakis M, Zerefos PG, Bitsika V, Esteban S, Frantzi M, Stravodimos K, Anagnou NP, Roubelakis MG, Sanchez-Carbayo M, Vlahou A. Zoidakis J, et al. Among authors: roubelakis mg. Mol Cell Proteomics. 2012 Apr;11(4):M111.009449. doi: 10.1074/mcp.M111.009449. Epub 2011 Dec 8. Mol Cell Proteomics. 2012. PMID: 22159600 Free PMC article.

8

Fetal mesenchymal stem cells in cancer therapy.

Bitsika V, Vlahou A, Roubelakis MG. Bitsika V, et al. Among authors: roubelakis mg. Curr Stem Cell Res Ther. 2013 Mar;8(2):133-43. doi: 10.2174/1574888x11308020004. Curr Stem Cell Res Ther. 2013. PMID: 23176305 Review.

9

Stem cells: insights into the secretome.

Makridakis M, Roubelakis MG, Vlahou A. Makridakis M, et al. Among authors: roubelakis mg. Biochim Biophys Acta. 2013 Nov;1834(11):2380-4. doi: 10.1016/j.bbapap.2013.01.032. Epub 2013 Jan 31. Biochim Biophys Acta. 2013. PMID: 23376432 Review.

10

AF-MSCs fate can be regulated by culture conditions.

Zagoura DS, Trohatou O, Bitsika V, Makridakis M, Pappa KI, Vlahou A, Roubelakis MG, Anagnou NP. Zagoura DS, et al. Among authors: roubelakis mg. Cell Death Dis. 2013 Apr 4;4(4):e571. doi: 10.1038/cddis.2013.93. Cell Death Dis. 2013. PMID: 23559005 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page